Literature DB >> 7523137

Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.

P Bowness1, R L Allen, A J McMichael.   

Abstract

The fine specificity of T cell recognition of peptide analogues of the influenza nucleoprotein epitope, NP 383-391 SRYWAIRTR, was studied using HLA B27-restricted influenza-specific cytotoxic T cell (CTL) clones, of defined T cell receptor (TcR) usage, derived from unrelated individuals following natural infection. Even conservative amino acid substitutions of the peptide residues P4, P7 and P8 influenced CTL recognition. These side chains are probably directly contacted by the TcR. CTL clones which used the TcR V alpha 14 gene segment (but not those using TcR V alpha 12) were also sensitive to P1 substitutions, suggesting that the TcR alpha chain of these clones lies over the N terminus of bound peptide, and that the "footprint" of certain TcR can span all exposed residues of a peptide bound to a major histocompatibility complex class I molecule. These results, taken together with previous structural and functional data, suggest that, for nonamer peptides bound to HLA B27, P1, P4 and P8 are "flag" residues with TcR-accessible side chains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523137     DOI: 10.1002/eji.1830241015

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation.

Authors:  Axel Trautmann; Beate Rückert; Peter Schmid-Grendelmeier; Eva Niederer; Eva-B Bröcker; Kurt Blaser; Cezmi A Akdis
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins.

Authors:  R Duchmann; C Lambert; E May; T Höhler; E Märker-Hermann
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 3.  The T cell receptor (TCR) in HLA-B27-restricted T cell responses--an introduction.

Authors:  E Märker-Hermann; R Duchmann; E May; B Ackermann; K H Meyer Zum Büschenfelde
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

4.  Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes.

Authors:  Elisa Nurzia; Daniele Narzi; Alberto Cauli; Alessandro Mathieu; Valentina Tedeschi; Silvana Caristi; Rosa Sorrentino; Rainer A Böckmann; Maria Teresa Fiorillo
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

5.  POPISK: T-cell reactivity prediction using support vector machines and string kernels.

Authors:  Chun-Wei Tung; Matthias Ziehm; Andreas Kämper; Oliver Kohlbacher; Shinn-Ying Ho
Journal:  BMC Bioinformatics       Date:  2011-11-15       Impact factor: 3.169

6.  Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1.

Authors:  P Romero; C Pannetier; J Herman; C V Jongeneel; J C Cerottini; P G Coulie
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

7.  CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis.

Authors:  M T Fiorillo; M Maragno; R Butler; M L Dupuis; R Sorrentino
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 8.  HLA-B27: natural function and pathogenic role in spondyloarthritis.

Authors:  Andrew McMichael; Paul Bowness
Journal:  Arthritis Res       Date:  2002-05-09

9.  T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.

Authors:  S R Burrows; S L Silins; D J Moss; R Khanna; I S Misko; V P Argaet
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

10.  Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space.

Authors:  Masato Ogishi; Hiroshi Yotsuyanagi
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.